Wustman; Brandon Alan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wustman; Brandon Alan.The latest application filed is for "method to predict response to pharmacological chaperone treatment of diseases".

Company Profile

1.9.11

Wustman; Brandon Alan - San Diego CA
Wustman; Brandon Alan - Princeton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases App 20210251971 - Benjamin; Elfrida ; et al.	2021-08-19
Method to predict response to pharmacological chaperone treatment of diseases Grant 10,813,921 - Benjamin , et al. October 27, 2	2020-10-27
Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases App 20190000818 - Benjamin; Elfrida ; et al.	2019-01-03
Method for the treatment of neurological disorders by enhancing the activity of .beta.-glucocerebrosidase Grant 10,064,851 - Wustman September 4, 2	2018-09-04
Treatment of CNS Disorders Associated with Mutations in Genes Encoding Lysosomal Enzymes App 20180133206 - Wustman; Brandon Alan	2018-05-17
Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases Grant 9,931,353 - Wustman , et al. April 3, 2	2018-04-03
Dosing Regimens for Treating And/Or Preventing Cerebral Amyloidoses App 20170273996 - Wustman; Brandon Alan	2017-09-28
Dosing regimens for treating and/or preventing cerebral amyloidoses Grant 9,675,627 - Wustman June 13, 2	2017-06-13
Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes Grant 9,597,324 - Wustman March 21, 2	2017-03-21
Method for the Treatment of Neurological Disorders by Enhancing the Activity of Beta-Glucocerebrosidase App 20170027919 - Wustman; Brandon Alan	2017-02-02
Method for the treatment of neurological disorders by enhancing the activity of .beta.-glucocerebrosidase Grant 9,402,837 - Wustman August 2, 2	2016-08-02
Dosing Regimens for Treating And/Or Preventing Cerebral Amyloidoses App 20160008383 - Wustman; Brandon Alan	2016-01-14
Method for Treating Cerebral Amyloid Angiopathy Using Pharmacological Chaperones to Increase the Activity of Gangliosidases App 20150374733 - Wustman; Brandon Alan ; et al.	2015-12-31
Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase Grant 9,119,845 - Wustman September 1, 2	2015-09-01
Treatment of CNS Disorders Associated with Mutations in Genes Encoding Lysosomal Enzymes App 20150133496 - Wustman; Brandon Alan	2015-05-14
Method for the Treatment of Neurological Disorders by Enhancing the Activity of Beta-Glucocerebrosidase App 20150025109 - Wustman; Brandon Alan	2015-01-22
Method For The Treatment Of Neurological Disorders By Enhancing The Activity Of Beta-glucocerebrosidase App 20110052613 - Wustman; Brandon Alan	2011-03-03
Method for the treatment of neurological disorders by enhancing the activity of .beta.-glucocerebrosidase Grant 7,829,579 - Wustman November 9, 2	2010-11-09
Method For The Treatment Of Neurological Disorders By Enhancing The Activity Of Beta-glucocerebrosidase App 20080009516 - Wustman; Brandon Alan	2008-01-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.